Inflammation, Allergy, and Immunology Journal Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Brunner Scott
|
Jan/Feb 2023
Pg. 22-23
|
Psoriasis Topical Ointment
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 57
|
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 446-466
|
Curcumin 2% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 509
|
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
|
Sep/Oct 2022
Pg. 364-368
|
Compounded Medications and Probiotics for Irritable Bowel Syndrome
Narváez Katherine Rivera, Thompson Tara
|
Sep/Oct 2022
Pg. 378-384
|
Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 430
|
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Riepl Mike
|
Jul/Aug 2022
Pg. 270-274
|
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy, Williams LaVonn
|
Jul/Aug 2022
Pg. 293-296
|
Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 318
|
Dexamethasone 1 mg/mL in Oral Mix
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 320
|
Indomethacin 1% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 325-326
|
Psoriasis Topical Ointment
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 329
|
Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops
Sahyoun Jean-Yves, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude
|
Jul/Aug 2022
Pg. 336-341
|
Cinnarizine 1 mg/mL in Oral Medium-Chain Triglycerides Anhydrous Vehicle
Allen Loyd V Jr
|
May/Jun 2022
Pg. 236
|
Sirolimus 0.1% Ointment
Allen Loyd V Jr
|
May/Jun 2022
Pg. 240
|
Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
|
May/Jun 2022
Pg. 241
|
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
|
Mar/Apr 2022
Pg. 94-98
|
Mesalamine 100-mg/mL Suspension Enema
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 144
|
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates)
Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
|
Mar/Apr 2022
Pg. 150-154
|
Ascorbic Acid 10% in Anhydrous PEG ointment
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 53
|
Diclofenac Sodium 1%-15% Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 55
|
Mometasone Furoate 0.1% Lotion
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 57
|
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Riepl Mike
|
Sep/Oct 2021
Pg. 372-377
|
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 416
|
Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application
Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli
|
Sep/Oct 2021
Pg. 422-426
|
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
|
Sep/Oct 2021
Pg. 431-439
|
Budesonide 0.0.25% Mucoadhesive Gel
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 323
|
Hydrocortisone 2-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 325
|
Tacrolimus 0.1% Topical Microemulsion
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 328
|
Calculations
Stockton Shelly J
|
May/Jun 2021
Pg. 230-231
|
Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension
Allen Loyd V Jr
|
May/Jun 2021
Pg. 234
|
Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags
Hui Ada, Yin Jian, Liu Wei, Zheng Kai
|
May/Jun 2021
Pg. 246-257
|
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 43
|
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 44
|
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 47
|
Design and Performance of an Inexpensive Water Activity Meter
Gilda Sagar S, Schober Joseph M, McPherson Timothy
|
Jan/Feb 2021
Pg. 48-51
|
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 315
|
Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 316
|
Hydroxyzine (Pamoate) 25-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 317
|
Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream)
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 320
|
Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis
Song Guiyun, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S
|
Jul/Aug 2020
Pg. 337-345
|
Dexamethasone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 225
|
Prednisolone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 229
|
Low-dose Naltrexone Therapy for Psoriasis
Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
|
Mar/Apr 2020
Pg. 94-96
|
Feasibility Study of Asthma Cream
Kuang Andrew
|
Mar/Apr 2020
Pg. 163-167
|
Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 57
|
LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 59
|
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 487
|
Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 490
|
Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 491
|
Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 410
|
Calculations
Stockton Shelly J
|
May/Jun 2019
Pg. 229
|
Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2019
Pg. 231
|
Flunisolide Nasal Spray
Allen Loyd V Jr
|
May/Jun 2019
Pg. 233
|
Methotrexate 2-mg/mL Oral Solution
Allen Loyd V Jr
|
May/Jun 2019
Pg. 235
|
Dexamethasone 2 mg/g Topical Paste, Veterinary
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 149
|
Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 150
|
Tacrolimus 0.5 mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 153
|
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2
Williams LaVonn A
|
Jan/Feb 2019
Pg. 14-21
|
Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 52
|
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 53
|
Hydrocortisone 2 mg/mL in Inorpha Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 495
|
Prednisone 5 mg/mL ir Oral Mix Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 497
|
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report
Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
|
Jul/Aug 2018
Pg. 270-278
|
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1
Williams LaVonn
|
Jul/Aug 2018
Pg. 284-287
|
Budesonide 1-mg//10-mL Mucolox Oral Suspensions
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 317
|
Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 319
|
Spironolactone 5-mg/mL in Suspendit Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 152
|
Trilostane 5-mg/mL in Cod Liver Oil Suspension (Vet)
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 153
|
Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 51
|
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 54
|
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 55
|
Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 58
|
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension
Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
|
Jan/Feb 2018
Pg. 66-75
|
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection
Wu George, Powers Dan, Yeung Stanley, Chen Frank
|
Jan/Feb 2018
Pg. 76-85
|
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride
Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
|
Jan/Feb 2018
Pg. 86-94
|
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 494
|
Tolmetin 400-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 497
|
Betamethasone 0.1% and Neomycin 0.6% Gel-Cream
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 312
|
Tacrolimus 0.06% Ophthalmic Drops
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 319
|
Tranilast 8% Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 321
|
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel
|
Jul/Aug 2017
Pg. 322-329
|
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt
Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
|
Jul/Aug 2017
Pg. 334-338
|
Meloxicam 1% Topical Gel
Allen Loyd V Jr
|
May/Jun 2017
Pg. 235
|
Azathioprine 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 146
|
Infliximab 1% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 62
|
Naproxen 5% Cream
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 410
|
Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations
Lupatini Nogueira Rodrigo José, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa
|
Jul/Aug 2016
Pg. 333-337
|
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Allen Loyd V Jr
|
May/Jun 2016
Pg. 228
|
Indomethacin Gel
Allen Loyd V Jr
|
May/Jun 2016
Pg. 230
|
Montelukast Sodium 5-mg Fast-Dissolving Film
Allen Loyd V Jr
|
May/Jun 2016
Pg. 232
|
Blue Goo Anti-Itch Gel
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 144
|
Medicated Polyox Bandage for Skin Ulcers
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 146
|
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Choo Winnie
|
Jan/Feb 2016
Pg. 6-10
|
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 51
|
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 508
|
Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
|
Sep/Oct 2015
Pg. 357-365
|
Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 405
|
Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg
Allen Loyd V
|
Jul/Aug 2015
Pg. 333
|
Stability of Prednisone in Oral Mix Suspending Vehicle
Friciu Mihaela, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim
|
Jul/Aug 2015
Pg. 337-339
|
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
|
May/Jun 2015
Pg. 243
|
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials
Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
|
May/Jun 2015
Pg. 261-267
|
Azathioprine 50-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 61
|
Hydroxychloroquine Sulfate 200-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 66
|
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions
Amin Alexandre, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica
|
Jan/Feb 2015
Pg. 73-77
|
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari
|
Sep/Oct 2014
Pg. 370-377
|
Ephedrine Sulfate 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 411
|
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation
Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
|
Sep/Oct 2014
Pg. 418-426
|
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition
Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
|
Sep/Oct 2014
Pg. 427-431
|
Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis
Reisacher William, Rudner Shara, Kotik Viktoriya
|
Jul/Aug 2014
Pg. 287-290
|
Choline Magnesium Trisalicylate Liquid
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 327
|
Denileukin Diftitox 150-mcg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 328
|
Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita, Addo Richard T
|
Jul/Aug 2014
Pg. 348-350
|
Cortisone Acetate 25-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 501
|
Hydrocortisone 50-mg/mL Injection (as the Sodium Succinate)
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 504
|
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
|
Sep/Oct 2013
Pg. 380-383
|
Indomethacin 1-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 419
|
Methotrexate 25-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 421
|
Phenylephrine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 422
|
Mercaptopurine 75-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 234
|
Prednisone 10-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 236
|
Adrenal Fatigue
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 39-44
|
Ibuprofen 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 67
|
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
|
Jan/Feb 2013
Pg. 74-85
View Sample |
Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents
Zur Eyal
|
Nov/Dec 2012
Pg. 462-469
|
Azathioprine 10-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 502
|
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies
Zur Eyal
|
Sep/Oct 2012
Pg. 386-393
|
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide
Zur Eyal
|
Jul/Aug 2012
Pg. 288-293
|
Betamethasone 0.6-mg/5-mL Syrup
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 332
|
Diphenhydramine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 334
|
Ketorolac Tromethamine 15-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 337
|
Treatment and Prevention of Insect Bites: Mosquitoes
Williams LaVonn A, Allen Loyd V Jr
|
May/Jun 2012
Pg. 210-218
|
Famotidine 10-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 242
|
Naloxone Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 244
|
Prochlorperazine 5-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 246
|
Ranitidine 25-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 247
|
Influence of Temperature on the Thirty-Day Chemical Stability of Extemporaneously Prepared Dexamethasone Paste
Dudley Richard, McDowell Brean, Mahl Carissa, Sarkar Arindam Basu
|
May/Jun 2012
Pg. 258-261
|
Promethazine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 163
|
Oral Mucositis: Etiology and Clinical and Pharmaceutical Management
Zur Eyal
|
Jan/Feb 2012
Pg. 22-33
|
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
|
Nov/Dec 2011
Pg. 458-463
|
Oxandrolone 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 505
|
Thioguanine 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 506
|
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags
Kaiser Jeanette, Kramer Irene
|
Nov/Dec 2011
Pg. 515-520
|
Rebamipide Rectal Enema Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 424
|
Cromolyn Sodium 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 336
|
Hydrocortisone 100-mg/60-mL Retention Enema
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 338
|
Magnesium Sulfate Paste
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 339
|
Treating Inner Ear Disorders with Intratympanic Drug Administration
McElhiney Linda F
|
Jul/Aug 2011
Pg. 302-307
|
Methylprednisolone 4-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 340
|
Oxandrolone 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 341
|
Treatment Options for Psoriasis
Williams LaVonn A, Humphreys Erica
|
May/Jun 2011
Pg. 204-213
|
Diclofenac Sodium 1% Topical Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 243
|
Ibuprofen 5% Topical Cream
Allen Loyd V Jr
|
May/Jun 2011
Pg. 244
|
Triamcinolone 0.1% Lotion
Allen Loyd V Jr
|
May/Jun 2011
Pg. 249
|
Current Concepts in the Treatment of Recurrent Aphthous Ulcers
Bramwell Bethany L, Williams LaVonn A
|
Jan/Feb 2011
Pg. 13-18
|
Diclofenac Sodium 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 64
|
Hydrocortisone Acetate 1% Gel, Alcohol-Free
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 65
|
Ibuprofen 5% Gel
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 66
|
Methotrexate 30-mg/g Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 68
|
Piroxicam 1% Gel
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 69
|
Chemical Stability of Brompheniramine Maleate in an Oral Liquid Dosage Form
Gupta Vishnu D, Gupta Vikas S
|
Jan/Feb 2011
Pg. 78-80
|
Capsaicin 0.05% Clear Medication Stick
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 517
|
Ketoprofen 2% Oral Gel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 521
|
Bromhexine Hydrochloride 0.8-mg/mL Syrup
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 516
|
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 520
|
Alpha-Bisabolol Mouthwash
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 420
|
Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study
Santoveña A, Llabrés M, Fariña JB
|
Sep/Oct 2010
Pg. 430-435
|
Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 427
|
Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 336
|
Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient
McElhiney Linda F
|
Mar/Apr 2010
Pg. 112-115
|
Acyclovir 200-mg/5-mL Oral Suspension (From the Injection)
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 151
|
Ketoprofen 100-mg/5-mL Mouth Rinse
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 68
|
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 74
|
A Review of Stomatitis and Treatment in Cats
Ray Jody D, Jordan Dinah G, Eubanks Diana L, Crosswhite Megan E
|
Sep/Oct 2009
Pg. 372-381
|
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Williams LaVonn A, Fokken Dawn
|
Sep/Oct 2009
Pg. 386-389
|
An Abridged History of Aspirin
Vance Dwight A
|
Sep/Oct 2009
Pg. 404-409
|
Dexamethasone and Furosemide Injection
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 335
|
Metronidazole 2.1-mg/mL in 5.25% Dextrose Injection
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 157
|
Nicotine Rectal Enema
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 158
|
Diphenhydramine Hydrochloride 25-mg Gelatin Troches
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 69
|
Excipient Choices for Special Populations
Nagel-Edwards Karen M, Ko James Y
|
Sep/Oct 2008
Pg. 426-430
|
Flurandrenolide Topical Film
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 451
|
Compounding Challenges for Immunocompromised Patients
McElhiney Linda F
|
Nov/Dec 2008
Pg. 482-487
|
Zirconium Oxide Lotion
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 364
|
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
|
Jul/Aug 2008
Pg. 295-304
|
Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization
Westrick Salisa C, Felkey Bill G
|
Jul/Aug 2008
Pg. 334-337
|
Tretinoin and (-)Alpha-Bisabolol Gel
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 360
|
Tretinoin and Dexpanthenol Gel
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 361
|
Cyclosporine Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 64
|
Diclofenac Sodium 1% Soft-Patch Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 65
|
Diclofenac Sodium 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 66
|
Flosulide 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 69
|
Piroxicam 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 71
|
Piroxicam 1% Soft-Patch Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 72
|
Betamethasone Valerate 0.1% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 419
|
Diclofenac Sodium 75-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 421
|
Hydrocortisone 0.5% Ethanolic Gel
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 423
|
Chemical Stability of Cyproheptadine Hydrochloride in an Oral Liquid Dosage Form
Gupta Vishnu D
|
Jul/Aug 2007
Pg. 347-348
|
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Gupta Vishnu D
|
May/Jun 2007
Pg. 259-261
|
Aspirin 80-mg/5-mL Oral Liquid, Anhydrous
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 154
|
Innovative Uses of Compounded Tranilast: An Interview with Compounding Pharmacist Larry J. Frieders, RPh
Vail Jane
|
Mar/Apr 2007
Pg. 132-135
|
Triprolidine Hydrochloride 0.25-mg/mL Syrup
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 163
|
Dexamethasone 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 72
|
Prednisone 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 77
|
Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 78
|
Cyclophosphamide 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 454
|
Indomethacin 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 458
|
Terbutaline Sulfate 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 460
|
In Vitro Transdermal Diffusion of Zileuton from a Topical Gel
Bigeleisen Paul E
|
Sep/Oct 2006
Pg. 392-395
|
Dapsone 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 300
|
Probiotic Therapy, Part 2: Clinical Perspectives
Vail Jane
|
May/Jun 2006
Pg. 195-200
|
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration
Trissel Lawrence A, Xu Quanyun A, Zhang Yanping
|
May/Jun 2006
Pg. 234-236
|
Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together
Gupta Vishnu D
|
May/Jun 2006
Pg. 237-239
|
Mycophenolate Mofetil 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 141
|
Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives
Vail Jane
|
Mar/Apr 2006
Pg. 107-111
|
Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery
Heim Bob
|
Jan/Feb 2006
Pg. 14-18
View Sample |
Mercaptopurine 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 64
|
Dexamethasone Oral Powder 10-mg Units, Veterinary
Allen Loyd V Jr
|
May/Jun 2005
Pg. 226
|